InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by ZACCARDELLI DAVID, Chief Executive Officer. Insider active across 1 companies, notably Verona Pharma plc. In total, 12 filings have been published. Total volume traded: €38k. The latest transaction was filed on 3 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€15,48932,904 shares@ €0.47070.5% of flow
Ordinary Shares
SEC:0001104659-22-056608:0·
€225,576454,864 shares@ €0.49596.7% of flow
Ordinary Shares
SEC:0001104659-22-055447:0·
€222,625334,448 shares@ €0.665628.3% of flow
Ordinary Shares
SEC:0001104659-22-011440·
€222,625334,448 shares@ €0.66566.6% of flow
Ordinary Shares
SEC:0001104659-22-011440:0·
€251,891454,848 shares@ €0.553832.0% of flow
Ordinary Shares
SEC:0001104659-21-133857·
€251,891454,848 shares@ €0.55387.4% of flow
Ordinary Shares
SEC:0001104659-21-133857:0·
€11,19217,656 shares@ €0.63391.4% of flow
Ordinary Shares
SEC:0001104659-21-102403·
€11,19217,656 shares@ €0.63390.3% of flow
Ordinary Shares
SEC:0001104659-21-102403:0·
€300,880454,848 shares@ €0.661538.3% of flow
Ordinary Shares
SEC:0001104659-21-100281·
€300,880454,848 shares@ €0.66158.9% of flow
Ordinary Shares
SEC:0001104659-21-100281:0·
€2m2,139,632 shares@ €0.735846.5% of flow
Ordinary Shares
SEC:0001104659-21-061710:0·
2,139,632 shares
Ordinary Shares
SEC:0001104659-21-061710·
12 of 12 declarations
About ZACCARDELLI DAVID
David Zaccardelli is the President and CEO of Verona Pharma plc. He leads the company's operations, focused on developing innovative treatments for respiratory diseases. With a strong background in the pharmaceutical industry, he is committed to advancing research and improving patient outcomes. His leadership is crucial for the growth strategy and success of Verona Pharma.
